Tralokinumab: Unveiling the Potential of LP 0162 and CAT-354 Tralokinumab, previously known as LP 0162 and CAT-354, represents a significant therapy for severe dermatitis. This monoclonal antibody inhibits https://nicoleookt909965.wikitelevisions.com/9553608/text